Looking Back, Looking Forward: Current Medications and Innovative Potential Medications to Treat Alcohol Use Disorder

被引:8
作者
Mason, Barbara J. [1 ,2 ]
机构
[1] Scripps Res Inst, Pearson Ctr Alcoholism & Addict Res, Dept Mol Med, La Jolla, CA USA
[2] Scripps Res Inst, Dept Mol Med, 10550 N Torrey Pines Rd,TPC-5, La Jolla, CA 92037 USA
来源
ALCOHOL RESEARCH-CURRENT REVIEWS | 2022年 / 42卷 / 01期
关键词
alcohol; alcohol use disorder; treatment; medication; disulfiram; naltrexone; acamprosate; DOUBLE-BLIND; DEPENDENCE; ACAMPROSATE; NALMEFENE; EFFICACY; GABAPENTIN; NALTREXONE; TOLERABILITY; DRINKING; STATES;
D O I
10.35946/arcr.v42.1.11
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
This article is part of a Festschrift commemorating the 50th anniversary of the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Established in 1970, first as part of the National Institute of Mental Health and later as an independent institute of the National Institutes of Health, NIAAA today is the world's largest funding agency for alcohol research. In addition to its own intramural research program, NIAAA supports the entire spectrum of innovative basic, translational, and clinical research to advance the diagnosis, prevention, and treatment of alcohol use disorder and alcohol-related problems. To celebrate the anniversary, NIAAA hosted a 2-day symposium, "Alcohol Across the Lifespan: 50 Years of Evidence-Based Diagnosis, Prevention, and Treatment Research," devoted to key topics within the field of alcohol research. This article is based on Dr. Mason's presentation at the event. NIAAA Director George F. Koob, Ph.D., serves as editor of the Festschrift.
引用
收藏
页数:10
相关论文
共 48 条
[1]  
Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP)., 2016, INTR HCUP NAT EM DEP
[2]  
Allen JP., 2003, Assessing Alcohol Problems: A Guide for Clinicians and Researchers, P37
[3]  
[Anonymous], 1994, Am J Psychiatry, V151, P1
[4]  
[Anonymous], 2000, International Guide for Monitoring Alcohol Consumption and Related Harm
[5]  
[Anonymous], 2019, Results from the 2018 National Survey on Drug Use and Health
[6]   Clinical Relevance of As-Needed Treatment with Nalmefene in Alcohol-Dependent Patients [J].
Aubin, Henri-Jean ;
Reimer, Jens ;
Nutt, David J. ;
Bladstrom, Anna ;
Torup, Lars ;
Francois, Clement ;
Chick, Jonathan .
EUROPEAN ADDICTION RESEARCH, 2015, 21 (03) :160-168
[7]  
Bazil CW, 2005, J CLIN SLEEP MED, V1, P284
[8]   The acute effects of gabapentin in combination with alcohol in heavy drinkers [J].
Bisaga, Adam ;
Evans, Suzette M. .
DRUG AND ALCOHOL DEPENDENCE, 2006, 83 (01) :25-32
[9]  
EMA E. M. A., 2010, GUID DEV MED PROD TR
[10]   Efficacy and tolerability of long-acting injectable for alcohol dependence - A randomized controlled trial [J].
Garbutt, JC ;
Kranzler, HR ;
O'Malley, SS ;
Gastfriend, DR ;
Pettinati, HM ;
Silverman, BL ;
Loewy, JW ;
Ehrich, EW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (13) :1617-1625